Report Detail
Global Non-invasive Liver Fibrosis Tester Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4658176 |
- 21 July, 2026 |
- Global |
- 117 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Non-invasive Liver Fibrosis Tester market size was valued at US$ 304 million in 2025 and is forecast to a readjusted size of US$ 550 million by 2032 with a CAGR of 9.0% during review period.
In 2025, global Non-invasive Liver Fibrosis Tester production reached approximately 3,837 units, with an average global market price of around US$77,000 per unit. Non-invasive Liver Fibrosis Tester is a specialized medical device or software used to detect and measure liver scarring (fibrosis) or stiffness without requiring a surgical liver biopsy. These devices are essential for diagnosing liver diseases (such as NAFLD, NASH, and hepatitis), staging the disease, and tracking treatment progress.
The global non-invasive liver fibrosis tester market features a competitive landscape dominated by leading enterprises, with a small number of international manufacturers holding core market shares through first-mover technological advantages and extensive clinical validation data. Their products have obtained approvals from major global regulatory authorities and are recommended in clinical guidelines by authoritative institutions including the World Health Organization, the European Association for the Study of the Liver, and the American Association for the Study of Liver Diseases. The industry's technical route is based on transient elastography, while evolving toward multimodal fusion and simultaneous multi-parameter detection. New-generation products integrate assessment capabilities for liver fibrosis, steatosis, and spleen stiffness, improving diagnostic accuracy and the value of full-course disease management. Clinical demand serves as the core driver of market growth. The high disease burden of chronic liver diseases drives continuous growth in demand for non-invasive screening tools among medical institutions. As an alternative to liver biopsy, non-invasive testing significantly reduces diagnostic risks and patient suffering, and improves screening compliance and dynamic monitoring efficiency. National medical insurance systems in multiple countries have gradually expanded coverage for relevant testing items, reducing patient payment burdens and further releasing market demand. Emerging markets have become important growth poles for the industry with the improvement of medical infrastructure and primary medical capabilities. The launch of portable devices accelerates the penetration of products into primary medical institutions. Chinese domestic enterprises have made important progress in core technology research and product registration. Their product performance has gradually approached the international advanced level, obtained regulatory certifications in many countries and regions, achieved rapid substitution in the domestic market, and started to expand overseas markets. The industry still faces some challenges. The diagnostic consistency of different technical routes needs to be further unified, and the physician operation training and quality control systems in primary medical institutions still need to be improved.
This report is a detailed and comprehensive analysis for global Non-invasive Liver Fibrosis Tester market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Non-invasive Liver Fibrosis Tester market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Non-invasive Liver Fibrosis Tester market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Non-invasive Liver Fibrosis Tester market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Non-invasive Liver Fibrosis Tester market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-invasive Liver Fibrosis Tester
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-invasive Liver Fibrosis Tester market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Echosens (Furui Medical), GE HealthCare, Royal Philips, Siemens Healthineers AG, Canon Medical, FUJIFILM Healthcare, Hologic, Wuxi Haisi Kaier Medical Technology, Shenzhen Energy Technology Group, Mindray, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Non-invasive Liver Fibrosis Tester market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Trolley-mounted
Portable
Market segment by Technology
Transient Elastography
Shear Wave Elastography
Market segment by Parameter
Single-parameter
Dual-/Multi-parameter
Market segment by Application
Hospitals & Clinics
Physical Examination Centers
Major players covered
Echosens (Furui Medical)
GE HealthCare
Royal Philips
Siemens Healthineers AG
Canon Medical
FUJIFILM Healthcare
Hologic
Wuxi Haisi Kaier Medical Technology
Shenzhen Energy Technology Group
Mindray
Eieling Technology Limited
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-invasive Liver Fibrosis Tester product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-invasive Liver Fibrosis Tester, with price, sales quantity, revenue, and global market share of Non-invasive Liver Fibrosis Tester from 2021 to 2026.
Chapter 3, the Non-invasive Liver Fibrosis Tester competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-invasive Liver Fibrosis Tester breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Non-invasive Liver Fibrosis Tester market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-invasive Liver Fibrosis Tester.
Chapter 14 and 15, to describe Non-invasive Liver Fibrosis Tester sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Non-invasive Liver Fibrosis Tester Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Trolley-mounted
- 1.3.3 Portable
- 1.4 Market Analysis by Technology
- 1.4.1 Overview: Global Non-invasive Liver Fibrosis Tester Consumption Value by Technology: 2021 Versus 2025 Versus 2032
- 1.4.2 Transient Elastography
- 1.4.3 Shear Wave Elastography
- 1.5 Market Analysis by Parameter
- 1.5.1 Overview: Global Non-invasive Liver Fibrosis Tester Consumption Value by Parameter: 2021 Versus 2025 Versus 2032
- 1.5.2 Single-parameter
- 1.5.3 Dual-/Multi-parameter
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Non-invasive Liver Fibrosis Tester Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Hospitals & Clinics
- 1.6.3 Physical Examination Centers
- 1.7 Global Non-invasive Liver Fibrosis Tester Market Size & Forecast
- 1.7.1 Global Non-invasive Liver Fibrosis Tester Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Non-invasive Liver Fibrosis Tester Sales Quantity (2021-2032)
- 1.7.3 Global Non-invasive Liver Fibrosis Tester Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Echosens (Furui Medical)
- 2.1.1 Echosens (Furui Medical) Details
- 2.1.2 Echosens (Furui Medical) Major Business
- 2.1.3 Echosens (Furui Medical) Non-invasive Liver Fibrosis Tester Product and Services
- 2.1.4 Echosens (Furui Medical) Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Echosens (Furui Medical) Recent Developments/Updates
- 2.2 GE HealthCare
- 2.2.1 GE HealthCare Details
- 2.2.2 GE HealthCare Major Business
- 2.2.3 GE HealthCare Non-invasive Liver Fibrosis Tester Product and Services
- 2.2.4 GE HealthCare Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 GE HealthCare Recent Developments/Updates
- 2.3 Royal Philips
- 2.3.1 Royal Philips Details
- 2.3.2 Royal Philips Major Business
- 2.3.3 Royal Philips Non-invasive Liver Fibrosis Tester Product and Services
- 2.3.4 Royal Philips Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Royal Philips Recent Developments/Updates
- 2.4 Siemens Healthineers AG
- 2.4.1 Siemens Healthineers AG Details
- 2.4.2 Siemens Healthineers AG Major Business
- 2.4.3 Siemens Healthineers AG Non-invasive Liver Fibrosis Tester Product and Services
- 2.4.4 Siemens Healthineers AG Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Siemens Healthineers AG Recent Developments/Updates
- 2.5 Canon Medical
- 2.5.1 Canon Medical Details
- 2.5.2 Canon Medical Major Business
- 2.5.3 Canon Medical Non-invasive Liver Fibrosis Tester Product and Services
- 2.5.4 Canon Medical Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Canon Medical Recent Developments/Updates
- 2.6 FUJIFILM Healthcare
- 2.6.1 FUJIFILM Healthcare Details
- 2.6.2 FUJIFILM Healthcare Major Business
- 2.6.3 FUJIFILM Healthcare Non-invasive Liver Fibrosis Tester Product and Services
- 2.6.4 FUJIFILM Healthcare Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 FUJIFILM Healthcare Recent Developments/Updates
- 2.7 Hologic
- 2.7.1 Hologic Details
- 2.7.2 Hologic Major Business
- 2.7.3 Hologic Non-invasive Liver Fibrosis Tester Product and Services
- 2.7.4 Hologic Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Hologic Recent Developments/Updates
- 2.8 Wuxi Haisi Kaier Medical Technology
- 2.8.1 Wuxi Haisi Kaier Medical Technology Details
- 2.8.2 Wuxi Haisi Kaier Medical Technology Major Business
- 2.8.3 Wuxi Haisi Kaier Medical Technology Non-invasive Liver Fibrosis Tester Product and Services
- 2.8.4 Wuxi Haisi Kaier Medical Technology Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Wuxi Haisi Kaier Medical Technology Recent Developments/Updates
- 2.9 Shenzhen Energy Technology Group
- 2.9.1 Shenzhen Energy Technology Group Details
- 2.9.2 Shenzhen Energy Technology Group Major Business
- 2.9.3 Shenzhen Energy Technology Group Non-invasive Liver Fibrosis Tester Product and Services
- 2.9.4 Shenzhen Energy Technology Group Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Shenzhen Energy Technology Group Recent Developments/Updates
- 2.10 Mindray
- 2.10.1 Mindray Details
- 2.10.2 Mindray Major Business
- 2.10.3 Mindray Non-invasive Liver Fibrosis Tester Product and Services
- 2.10.4 Mindray Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Mindray Recent Developments/Updates
- 2.11 Eieling Technology Limited
- 2.11.1 Eieling Technology Limited Details
- 2.11.2 Eieling Technology Limited Major Business
- 2.11.3 Eieling Technology Limited Non-invasive Liver Fibrosis Tester Product and Services
- 2.11.4 Eieling Technology Limited Non-invasive Liver Fibrosis Tester Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Eieling Technology Limited Recent Developments/Updates
3 Competitive Environment: Non-invasive Liver Fibrosis Tester by Manufacturer
- 3.1 Global Non-invasive Liver Fibrosis Tester Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Non-invasive Liver Fibrosis Tester Revenue by Manufacturer (2021-2026)
- 3.3 Global Non-invasive Liver Fibrosis Tester Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Non-invasive Liver Fibrosis Tester by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Non-invasive Liver Fibrosis Tester Manufacturer Market Share in 2025
- 3.4.3 Top 6 Non-invasive Liver Fibrosis Tester Manufacturer Market Share in 2025
- 3.5 Non-invasive Liver Fibrosis Tester Market: Overall Company Footprint Analysis
- 3.5.1 Non-invasive Liver Fibrosis Tester Market: Region Footprint
- 3.5.2 Non-invasive Liver Fibrosis Tester Market: Company Product Type Footprint
- 3.5.3 Non-invasive Liver Fibrosis Tester Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Non-invasive Liver Fibrosis Tester Market Size by Region
- 4.1.1 Global Non-invasive Liver Fibrosis Tester Sales Quantity by Region (2021-2032)
- 4.1.2 Global Non-invasive Liver Fibrosis Tester Consumption Value by Region (2021-2032)
- 4.1.3 Global Non-invasive Liver Fibrosis Tester Average Price by Region (2021-2032)
- 4.2 North America Non-invasive Liver Fibrosis Tester Consumption Value (2021-2032)
- 4.3 Europe Non-invasive Liver Fibrosis Tester Consumption Value (2021-2032)
- 4.4 Asia-Pacific Non-invasive Liver Fibrosis Tester Consumption Value (2021-2032)
- 4.5 South America Non-invasive Liver Fibrosis Tester Consumption Value (2021-2032)
- 4.6 Middle East & Africa Non-invasive Liver Fibrosis Tester Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Non-invasive Liver Fibrosis Tester Sales Quantity by Type (2021-2032)
- 5.2 Global Non-invasive Liver Fibrosis Tester Consumption Value by Type (2021-2032)
- 5.3 Global Non-invasive Liver Fibrosis Tester Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Non-invasive Liver Fibrosis Tester Sales Quantity by Application (2021-2032)
- 6.2 Global Non-invasive Liver Fibrosis Tester Consumption Value by Application (2021-2032)
- 6.3 Global Non-invasive Liver Fibrosis Tester Average Price by Application (2021-2032)
7 North America
- 7.1 North America Non-invasive Liver Fibrosis Tester Sales Quantity by Type (2021-2032)
- 7.2 North America Non-invasive Liver Fibrosis Tester Sales Quantity by Application (2021-2032)
- 7.3 North America Non-invasive Liver Fibrosis Tester Market Size by Country
- 7.3.1 North America Non-invasive Liver Fibrosis Tester Sales Quantity by Country (2021-2032)
- 7.3.2 North America Non-invasive Liver Fibrosis Tester Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Non-invasive Liver Fibrosis Tester Sales Quantity by Type (2021-2032)
- 8.2 Europe Non-invasive Liver Fibrosis Tester Sales Quantity by Application (2021-2032)
- 8.3 Europe Non-invasive Liver Fibrosis Tester Market Size by Country
- 8.3.1 Europe Non-invasive Liver Fibrosis Tester Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Non-invasive Liver Fibrosis Tester Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Non-invasive Liver Fibrosis Tester Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Non-invasive Liver Fibrosis Tester Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Non-invasive Liver Fibrosis Tester Market Size by Region
- 9.3.1 Asia-Pacific Non-invasive Liver Fibrosis Tester Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Non-invasive Liver Fibrosis Tester Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Non-invasive Liver Fibrosis Tester Sales Quantity by Type (2021-2032)
- 10.2 South America Non-invasive Liver Fibrosis Tester Sales Quantity by Application (2021-2032)
- 10.3 South America Non-invasive Liver Fibrosis Tester Market Size by Country
- 10.3.1 South America Non-invasive Liver Fibrosis Tester Sales Quantity by Country (2021-2032)
- 10.3.2 South America Non-invasive Liver Fibrosis Tester Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Non-invasive Liver Fibrosis Tester Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Non-invasive Liver Fibrosis Tester Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Non-invasive Liver Fibrosis Tester Market Size by Country
- 11.3.1 Middle East & Africa Non-invasive Liver Fibrosis Tester Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Non-invasive Liver Fibrosis Tester Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Non-invasive Liver Fibrosis Tester Market Drivers
- 12.2 Non-invasive Liver Fibrosis Tester Market Restraints
- 12.3 Non-invasive Liver Fibrosis Tester Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Non-invasive Liver Fibrosis Tester and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Non-invasive Liver Fibrosis Tester
- 13.3 Non-invasive Liver Fibrosis Tester Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Non-invasive Liver Fibrosis Tester Typical Distributors
- 14.3 Non-invasive Liver Fibrosis Tester Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Non-invasive Liver Fibrosis Tester. Industry analysis & Market Report on Non-invasive Liver Fibrosis Tester is a syndicated market report, published as Global Non-invasive Liver Fibrosis Tester Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Non-invasive Liver Fibrosis Tester market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
